Nutex Health (NUTX) Competitors $25.05 +0.05 (+0.20%) (As of 09/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NUTX vs. GRVY, MXCT, ABSI, BWMN, TIXT, RGP, ACCD, OOMA, IBEX, and PMTSShould you be buying Nutex Health stock or one of its competitors? The main competitors of Nutex Health include Gravity (GRVY), MaxCyte (MXCT), Absci (ABSI), Bowman Consulting Group (BWMN), TELUS International (Cda) (TIXT), Resources Connection (RGP), Accolade (ACCD), Ooma (OOMA), IBEX (IBEX), and CPI Card Group (PMTS). These companies are all part of the "business services" industry. Nutex Health vs. Gravity MaxCyte Absci Bowman Consulting Group TELUS International (Cda) Resources Connection Accolade Ooma IBEX CPI Card Group Gravity (NASDAQ:GRVY) and Nutex Health (NASDAQ:NUTX) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation. Do analysts prefer GRVY or NUTX? Nutex Health has a consensus price target of $45.00, suggesting a potential upside of 79.64%. Given Nutex Health's higher probable upside, analysts clearly believe Nutex Health is more favorable than Gravity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gravity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ANutex Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor GRVY or NUTX? In the previous week, Gravity had 6 more articles in the media than Nutex Health. MarketBeat recorded 9 mentions for Gravity and 3 mentions for Nutex Health. Nutex Health's average media sentiment score of 0.71 beat Gravity's score of 0.25 indicating that Nutex Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gravity 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Nutex Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, GRVY or NUTX? Gravity has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Gravity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGravity$564.42B0.00$105.61M$13.234.46Nutex Health$275.93M0.45-$45.79M-$10.59-2.37 Is GRVY or NUTX more profitable? Gravity has a net margin of 14.87% compared to Nutex Health's net margin of -13.73%. Gravity's return on equity of 37.85% beat Nutex Health's return on equity.Company Net Margins Return on Equity Return on Assets Gravity14.87% 37.85% 30.67% Nutex Health -13.73%-43.79%-8.89% Do institutionals and insiders hold more shares of GRVY or NUTX? 9.9% of Gravity shares are held by institutional investors. Comparatively, 5.3% of Nutex Health shares are held by institutional investors. 38.5% of Nutex Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk & volatility, GRVY or NUTX? Gravity has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Does the MarketBeat Community prefer GRVY or NUTX? Gravity received 182 more outperform votes than Nutex Health when rated by MarketBeat users. However, 100.00% of users gave Nutex Health an outperform vote while only 61.56% of users gave Gravity an outperform vote. CompanyUnderperformOutperformGravityOutperform Votes18961.56% Underperform Votes11838.44% Nutex HealthOutperform Votes7100.00% Underperform VotesNo Votes SummaryGravity beats Nutex Health on 11 of the 17 factors compared between the two stocks. Ad Porter & CompanyI’m giving you the name of this investment for freeNow that the Federal Reserve lowered interest rates, this investment could easily go up 50%.Watch now and pay close attention at the 25-minute mark. Get Nutex Health News Delivered to You Automatically Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUTX vs. The Competition Export to ExcelMetricNutex HealthBusiness services IndustryMedical SectorNASDAQ ExchangeMarket Cap$124.55M$19.24B$5.51B$8.27BDividend YieldN/A2.37%4.34%4.08%P/E Ratio-2.3643.38144.1718.62Price / Sales0.455.721,690.1471.04Price / CashN/A26.9236.8431.89Price / Book1.425.444.834.54Net Income-$45.79M$528.55M$115.08M$224.30M7 Day Performance8.25%1.30%4.03%5.57%1 Month Performance64.26%3.08%9.54%8.86%1 Year Performance-30.53%14.91%29.08%12.05% Nutex Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRVYGravity1.4181 of 5 stars1.42 / 5 stars$63.83+0.1%N/A-13.9%$443.56M$564.42B4.82340High Trading VolumeMXCTMaxCyte2.6378 of 5 stars2.64 / 5 stars$4.00+2.3%$8.67+116.7%+19.9%$419.30M$45.44M-11.4380Positive NewsABSIAbsci2.0328 of 5 stars2.03 / 5 stars$3.69+1.1%$8.40+127.6%+156.5%$417.28M$3.25M-3.18210Short Interest ↑BWMNBowman Consulting Group3.0297 of 5 stars3.03 / 5 stars$23.00+2.5%$40.10+74.3%-8.4%$406.34M$386.81M-34.332,000Short Interest ↑TIXTTELUS International (Cda)4.1166 of 5 stars4.12 / 5 stars$3.67-0.3%$7.55+105.8%-54.7%$392.07M$2.71B24.4775,347Positive NewsRGPResources Connection4.7179 of 5 stars4.72 / 5 stars$9.86+1.2%$13.00+31.8%-33.5%$333.34M$632.80M14.943,376Analyst RevisionNews CoverageACCDAccolade4.7931 of 5 stars4.79 / 5 stars$3.93+0.5%$11.65+196.5%-64.8%$314.43M$431.53M-3.392,400Gap UpOOMAOoma2.9529 of 5 stars2.95 / 5 stars$11.23+1.4%$14.50+29.1%-14.7%$296.47M$248.16M-112.301,221Positive NewsIBEXIBEX2.5312 of 5 stars2.53 / 5 stars$16.73+1.6%$19.20+14.8%+40.6%$287.99M$508.47M10.9329,863Analyst ForecastInsider SellingShort Interest ↓News CoveragePMTSCPI Card Group4.298 of 5 stars4.30 / 5 stars$25.79+1.4%$34.67+34.4%+39.7%$286.84M$439.49M16.431,448 Related Companies and Tools Related Companies: Gravity Alternatives MaxCyte Alternatives Absci Alternatives Bowman Consulting Group Alternatives TELUS International (Cda) Alternatives Resources Connection Alternatives Accolade Alternatives Ooma Alternatives IBEX Alternatives CPI Card Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NUTX) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutex Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.